Fortrea Holdings (FTRE) Net Cash Flow (2022 - 2026)
Fortrea Holdings (FTRE) posted Net Cash Flow of -$25.0 million for Q1 2026, down 154.47% on a QoQ basis from $45.9 million in Q4 2025, and down 26.9% year-over-year from -$34.2 million in Q1 2025.
Fortrea Holdings (FTRE) Net Cash Flow (2022 - 2026) Analysis & Trends
Fortrea Holdings' Net Cash Flow history runs 5 years deep, the most recent figure standing at -$25.0 million for Q1 2026.
- Quarterly Net Cash Flow fell 26.9% year-over-year to -$25.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $46.3 million (up 345.19% YoY) and the FY2025 annual result came in at $51.6 million, up 210.84% from the prior year.
- Net Cash Flow was -$25.0 million for Q1 2026 at Fortrea Holdings, down from $45.9 million in the prior quarter.
- Across five years, Net Cash Flow topped out at $50.1 million in Q3 2025 and bottomed at -$25.0 million in Q1 2026.
- A 5-year average of $3.7 million and a median of -$800000.0 in 2022 frame the typical range for Net Cash Flow.
- Peak annual rise in Net Cash Flow reached 1047.06% in 2024, while the deepest fall reached 690.32% in 2024.
- Fortrea Holdings' Net Cash Flow stood at -$800000.0 in 2022, then surged by 312.5% to $1.7 million in 2023, then jumped by 1047.06% to $19.5 million in 2024, then jumped by 135.38% to $45.9 million in 2025, then slumped by 154.47% to -$25.0 million in 2026.
- Business Quant data shows FTRE's Net Cash Flow at -$25.0 million in Q1 2026, $45.9 million in Q4 2025, and $50.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 10.56 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 224.46 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.34 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 457.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -152.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 57.19 Mn |
| 10 | Fortrea Holdings | 1.83 Bn | 1.68 Bn | 123.60 Mn | -25.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -25.00 Mn |
| Mar 31, 2026 | -25.00 Mn |
| Dec 31, 2025 | 45.90 Mn |
| Dec 31, 2025 | 45.90 Mn |
| Sep 30, 2025 | 50.10 Mn |
| Sep 30, 2025 | 50.10 Mn |
| Jun 30, 2025 | -24.70 Mn |
| Jun 30, 2025 | -24.70 Mn |
| Mar 31, 2025 | -19.70 Mn |
| Mar 31, 2025 | -19.70 Mn |
| Dec 31, 2024 | 19.50 Mn |
| Dec 31, 2024 | 19.50 Mn |
| Sep 30, 2024 | -24.50 Mn |
| Sep 30, 2024 | -24.50 Mn |
| Jun 30, 2024 | 35.10 Mn |
| Jun 30, 2024 | 35.10 Mn |
| Mar 31, 2024 | -13.50 Mn |
| Mar 31, 2024 | -13.50 Mn |
| Dec 31, 2023 | 1.70 Mn |
| Dec 31, 2023 | 1.70 Mn |